Synthetic elements made entirely of RNA are suitable as regulatory elements in genetically modified systems and as biosensors. Such RNA aptamers are highly structured nucleotide sequences capable of specifically binding a target molecule. De novo selection of aptamers against a wide variety of potential targets is possible. By integrating RNA aptamers as binding domains into natural or synthetically designed regulatory circuits in the form of so-called riboswitches, new regulatory mechanisms can be generated that do not require additional regulatory elements. In addition, these binding domains can be used in cell-free systems to perform highly specific and affine molecular detection assays. By presenting two well-established aptamer designs, we aim to demonstrate the potential of RNA aptamer-based riboswitches and biosensors in various applications.
No takes yet. Share an insight, caveat, or question.
Kelvin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: